Significantly, Kaplan–Meier survival analysis, using a microarray data set from 3,458 breast cancer patients, revealed high Eg5 mRNA level was significantly associated with worse overall survival (P=0) (Fig. 7d), especially for patients with luminal A and B subtype breast tumours. Here, KIF11 is linked to breast neoplasm.